SCHEMBL2729937

SCHEMBL2729937

CCN(Cc1ccco1)C(=O)/C=C/c1ccc2c(c1)OCO2

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 11/20 0.73
▸ HPGD P15428 3/20 0.61
▸ POLB P06746 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ CYP3A4 P08684 1/20 0.58
▸ RAB9A P51151 2/20 0.56
▸ MAPT P10636 1/20 0.56
▸ GABRA1 P14867 2/20 0.54
▸ GABRG2 P18507 2/20 0.54
▸ GABRB3 P28472 2/20 0.54
▸ GABRA3 P34903 2/20 0.54
▸ GABRA2 P47869 2/20 0.54
▸ GABRB2 P47870 2/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2729939 1.00 TRPM8 (0.73) TRPM8HPGDPOLBKDM4EALDH1A1
SCHEMBL28408661 0.85 TRPM8 (1.00) TRPM8HPGDKDM4EALDH1A1CYP3A4
SCHEMBL10270783 0.85 TRPM8 (1.00) TRPM8HPGDKDM4EALDH1A1CYP3A4
SCHEMBL10270782 0.84 TRPM8 (1.00) TRPM8HPGDCYP3A4RAB9AGABRA1
SCHEMBL2730551 0.81 SNCA (0.47) TRPM8HPGDPOLBKDM4EALDH1A1
SCHEMBL2729869 0.81 TRPM8 (1.00) TRPM8HPGDKDM4EALDH1A1CYP3A4
SCHEMBL2730618 0.81 TRPM8 (0.75) TRPM8HPGDKDM4EALDH1A1CYP3A4
SCHEMBL30582799 0.81 SNCA (0.47) TRPM8HPGDPOLBKDM4EALDH1A1
SCHEMBL2730615 0.81 TRPM8 (0.75) TRPM8HPGDKDM4EALDH1A1CYP3A4
SCHEMBL2729866 0.81 TRPM8 (1.00) TRPM8HPGDKDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132323-A1 COMPOSITIONS COMPRISING A SUNSCREEN ACTIVE AGENT DSM-FIRMENICH AG (CH) 2025-06-26 — — WO disclosed
CN-118697922-A Perfume dispersing device 弗门尼舍有限公司 2024-09-27 — — CN disclosed
CN-109414048-B Coated yeast formulation 弗门尼舍有限公司 2023-09-01 — — CN disclosed
US-11234450-B2 Preparations having a cooling effect SYMRISE AG (DE) 2022-02-01 — — US disclosed
US-10953007-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-03-23 — — US disclosed
EP-3470407-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-17 — — EP disclosed
US-10182584-B2 Cooling preparations SYMRISE AG (DE) 2019-01-22 — — US disclosed
US-10016418-B2 Compounds useful as modulators of TRPM8 Seaomyx, Inc. (US) 2018-07-10 — — US disclosed
US-10016418-B2 Compounds useful as modulators of TRPM8 Seaomyx, Inc. (US) 2018-07-10 — — US disclosed
US-20180055069-A1 PREPARATIONS SYMRISE AG (DE) 2018-03-01 — — US disclosed
US-9394287-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2016-07-19 — — US disclosed
US-9394287-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2016-07-19 — — US disclosed
US-20150313820-A1 PREPARATIONS SYMRISE AG (DE) 2015-11-05 — — US disclosed
US-20150313820-A1 PREPARATIONS SYMRISE AG (DE) 2015-11-05 — — US disclosed
EP-2635572-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2013-09-11 — — EP disclosed
CN-103201279-A Compounds useful as modulators of TRPM8 SENOMYX INC 2013-07-10 — — CN disclosed
WO-2012061698-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-09-13 — — WO disclosed
WO-2012061698-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-09-13 — — WO disclosed
WO-2012061698-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-05-10 — — WO disclosed
WO-2012061698-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10953007-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885HPGD 1694/4885POLB 4439/4885
US-11234450-B2 Preparations having a cooling effect CRAT, CPT2, CPT1A TRPM8 60/4885HPGD 2629/4885POLB 1521/4885
US-10016418-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885HPGD 1694/4885POLB 4439/4885
US-10182584-B2 Cooling preparations CRAT, ACAT2, TAS2R50 TRPM8 62/4885HPGD 2379/4885POLB 1528/4885
US-20180055069-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885HPGD 2263/4885POLB 1657/4885
US-20150313820-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885HPGD 2263/4885POLB 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback